¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦39Â÷ KSTH Ãß°èÇмú´ëȸ : 2021-09-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦39Â÷ KSTH Ãß°èÇмú´ëȸ : 2021-09-03
±³À°ÀÏÀÚ : 2021-09-03
±³À°Àå¼Ò : ¿Â-¿ÀÇÁ¶óÀÎ º´Çà  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà) Á¦39Â÷ KSTH Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ
´ã´çÀÚ : ±èÁø¾Æ
¿¬¶ôó : 042-484-2426  
À̸ÞÀÏ : ksth@thrombo.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú, °áÇÙ°ú, Áø´Ü°Ë»çÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаúÀÇ»çÇÐ, ¿¹¹æÀÇÇÐ, »ý¸®ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ÀÇ·á»çȸÇÐ, ÀÇ·áÀ±¸®ÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥, ÀÇ·á¹ý, ÀÇ·á°æ¿µ, ±âŸ
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 10,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 10:00~10:20 Current status of aHUS in Korea  ¾È¼­¿¬(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 10:20~10:45 Differential diagnosis of thrombotic microangiopathy  °í¿µÀÏ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 10:45~11:10 Optimal use of eculizumab in the treatment of aHUS in Korea  ±èÁø¼®(¿¬¼¼ÀÇ´ë) 
Åä·Ð 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 11:10~11:30 Panel discussion  ¹®¿µÃ¶ÀåÁØÈ£(ÀÌÈ­ÀǴ뼺±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 11:30~13:00 Lunch ¹× Oral presentation  ¹æ¼ö¹Ì À̽ÂÈñ ±è¼öÁ¾(¼­¿ïÀÇ´ë ±¹¸³º¸°Ç¿¬±¸¿ø ÃæºÏ´ë ÀÇÇаú) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 13:00~13:25 Update of Optimal Antithrombotic Therapy after TAVR  ¹ÎÇʱâ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 13:25~13:50 Cutting Edge on Optimal Therapy for Pulmonary Embolism  È²Çå±Ô(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 13:50~14:15 Present and Future of Aspirin as Primary Prevention of ASCVD  ³ª»óÈÆ(¼­¿ïÀÇ´ë) 
Åä·Ð 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 14:15~14:30 Panel discussion  Çã¾Ö¿µ½ÉµÎ¼±(°­¿øÀÇ´ëÀü³²ÀÇ´ë) 
È޽Ġ09-03  14:30~15:00 Coffee Break  () 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 15:00~15:25 Management of Antithrombotic Agents for Patients undergoing Procedure/Operation  À§Áø(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 15:25~15:50 Cardiovascular Oncology: Optimal Antithrombotic Therapy in Cancer Patients  Á¶ÀÎÁ¤(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 15:50~16:15 Antithrombotic therapy for acute stage and secondary prevention of stroke  À̵¿È¯(À»ÁöÀÇ´ë) 
Åä·Ð 09-03 ¿Â¶óÀÎ ¹× ´Ù¾Æ¸ÁȦ 16:15~16:30 Panel discussion  ½Åµ¿È£°­¹Î°æ(¿¬¼¼ÀÇ´ëÇѸ²ÀÇ´ë) 
±âŸ 09-03  16:30~17:00 ¿ì¼ö¿¬Á¦»ó ¹ßÇ¥ ¹× ½Ã»ó  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¦39Â÷ KSTH Ãß°èÇмú´ëȸ : 2021-09-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦77Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2021) 3ÀÏÂ÷ : 2021-09-03
´ÙÀ½±Û Çѱ¹ÀÇÇб³À°ÇÐȸ (¿Â¶óÀÎ) 2021³âµµ ÇϹݱ⠽ÅÀÓ±³¼ö ¿öÅ©¼ó (2ÀÏÂ÷) : 2021-09-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
375 ¼­¿ï 2018³â Á¦31ȸ ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ Á¤±âÇмú´ëȸ ¹× ÃÑȸ : 2018-08-25 0 636 2018-08-15
374 ÀÎõ ´ëÇѽ½°üÀýÇÐȸ Á¦5ȸ Korea-Japan Knee Osteotomy Symposium : 2018-08-25 0 1,358 2018-08-15
373 °­¿ø 2018³â ´ëÇѹÙÀÌ·¯½ºÇÐȸ ¿¬±¸È¸¿¬ÇÕ Á¤±âÇмú´ëȸ : 2018-08-24 0 344 2018-08-15
372 ¼­¿ï ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Ư°­ : 2018-08-23 0 307 2018-08-15
371 Àü³² ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ 283Â÷ ¿ù·ÊÁý´ãȸ : 2018-08-23 0 648 2018-08-15
370 ¼­¿ï ´ëÇÑ°³¿øÀÇÇùÀÇȸ Á¦4ȸ µÎ°æºÎ ÃÊÀ½ÆÄ ¿¬¼ö ¼¼¹Ì³ª : 2018-09-30 0 1,958 2018-08-08
369 ´ë±¸ ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ ´ë±¸¡¤°æºÏ ÁöºÎȸ Á¦2Â÷ ÇмúÁý´ãȸ : 2018-09-20 0 542 2018-08-08
368 °æ³² ´ëÇѼҾưúÇÐȸ °³Á¤µÈ °¡¿Í»çÅ°º´ Áø·áÁöħ¿Ü 1°Ç : 2018-09-20 0 783 2018-08-08
367 °­¿ø ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ °­¿øÁöȸ Áý´ãȸ : 2018-09-15 0 1,164 2018-08-08
366 °æ±â ±¹¸³¾Ï¼¾ÅÍ ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ǹ®´õ½Ê°úÁ¤ : 2018-09-15 0 595 2018-08-08
365 Àü³² Çѱ¹°£´ãÃé¿Ü°úÇÐȸ Á¦13Â÷ ±¹Á¦½Ì±ÛÅäÇȽÉÆ÷Áö¿ò : 2018-09-14 0 1,063 2018-08-08
364 ºÎ»ê ºÎ»ê¼Ò¾Æ°úÇÐȸ Á¤±â Çмú Áý´äȸ : 2018-09-13 0 1,501 2018-08-08
363 ´ë±¸ ´ëÇÑÄ¡¸ÅÇÐȸ ´ë±¸°æºÏÁöȸ 2018 Ãß°è ½ÉÆ÷Áö¿ò : 2018-09-13 0 480 2018-08-08
362 ÀüºÏ Á¦6ȸ ÀüºÏ´ëÇб³º´¿ø Áö¿ªÀǾàÇ°¾ÈÀü¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2018-09-11 0 370 2018-08-08
361 ¼­¿ï ´ëÇѼҾư¨¿°ÇÐȸ Á¦17ȸ ¿¬¼ö°­Á : 2018-09-09 0 498 2018-08-08
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷